BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29978784)

  • 21. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase.
    Xia Z; Tang M; Ma J; Zhang H; Gimple RC; Prager BC; Tang H; Sun C; Liu F; Lin P; Mei Y; Du R; Rich JN; Xie Q
    Nucleic Acids Res; 2021 Jul; 49(13):7361-7374. PubMed ID: 34181729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
    Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
    Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
    Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N
    Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
    Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
    Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
    Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
    Li D; Fu Z; Dong C; Song Y
    Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.
    Feng Z; Li Q; Meng R; Yi B; Xu Q
    J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.
    Meng F; Liu Y; Chen Q; Ma Q; Gu S; Cui R; Cao R; Zhao M
    Am J Physiol Renal Physiol; 2020 Nov; 319(5):F839-F847. PubMed ID: 32954854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.
    Huang X; Yang Z; Li Y; Long X
    Ann Hematol; 2023 Jul; 102(7):1801-1810. PubMed ID: 37222774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL3 relieved the injury of SH-SY5Y cells treated with lipopolysaccharide and exposed to sevoflurane through regulating the m6A levels of Sox2.
    Wang Y; Yang Z
    Brain Behav; 2023 May; 13(5):e2936. PubMed ID: 36977205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
    Li S; Jiang F; Chen F; Deng Y; Pan X
    J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative splicing of METTL3 explains apparently METTL3-independent m6A modifications in mRNA.
    Poh HX; Mirza AH; Pickering BF; Jaffrey SR
    PLoS Biol; 2022 Jul; 20(7):e3001683. PubMed ID: 35853000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of N6-adenosine-methyltransferase subunits METTL3 and METTL14 in the biological properties of periodontal ligament cells.
    Huang J; Guo C; Wang Y; Zhou Y
    Tissue Cell; 2023 Jun; 82():102081. PubMed ID: 37018927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
    Xu J; Chen Q; Tian K; Liang R; Chen T; Gong A; Mathy NW; Yu T; Chen X
    Oncol Rep; 2020 Sep; 44(3):973-986. PubMed ID: 32705223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methyltransferase-like 3-mediated N6-methyladenosine modification of miR-7212-5p drives osteoblast differentiation and fracture healing.
    Mi B; Xiong Y; Yan C; Chen L; Xue H; Panayi AC; Hu L; Hu Y; Zhou W; Cao F; Liu G
    J Cell Mol Med; 2020 Jun; 24(11):6385-6396. PubMed ID: 32307908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.